BRAIN Biotech AG

Equities

BNN

DE0005203947

Market Closed - Xetra Other stock markets 11:35:42 2026-01-16 am EST			5-day change	1st Jan Change
2.420 ^EUR	-1.63%		-12.00%	-3.97%

Jan. 14	BRAIN Biotech AG Provides Revenue Guidance for the Year 2025/2026	CI
Jan. 13	BRAIN Biotech AG Reports Earnings Results for the Full Year Ended September 30, 2025	CI

Transcript : BRAIN Biotech AG, Q2 2023 Earnings Call, May 25, 2023

Published on 05/25/2023 at 05:00 am EDT

S&P Capital IQ

Presenter Speech
Michael Schneiders (Executives)

Hello. My name is Michael Schneiders. I'm the CFO of BRAIN Biotech AG. We are located in Germany, just between Frankfurt and Sternberg. And I'm very

This article is reserved for subscribers

Unlock the article : SUBSCRIBE!

Already a customer? Log In

Latest news about BRAIN Biotech AG

Jan. 14	BRAIN Biotech AG Provides Revenue Guidance for the Year 2025/2026	CI
Jan. 13	BRAIN Biotech AG Reports Earnings Results for the Full Year Ended September 30, 2025	CI
25-09-03	BRAIN Biotech AG Announces Executive Changes	CI
25-08-28	BRAIN Biotech AG Reports Earnings Results for the Third Quarter and Nine Months Ended June 30, 2025	CI
25-08-28	BRAIN Biotech AG Updates Sales Guidance for the Year 2025	CI
25-08-25	Corbion, BRAIN Biotech to Jointly Develop Biobased Antimicrobial Compounds	MT
25-08-25	Corbion and Brain Biotech Ag Team to Shape the Future of Innovation in Nature-Based Ingredient Technologies	CI
25-07-23	Brain Biotech Ag Appoints Ursula La Cognata as Member of Supervisory Board, Effective July 11, 2025	CI
25-05-28	BRAIN Biotech AG Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2025	CI
25-05-20	Brain Biotech Takes Full Control of Dutch Unit Breatec, Plans New Continental Europe Hub	MT
25-05-20	BRAIN Biotech AG Announces Buy-Out of Minorities, New Continental European Production Site, and Expansion of Its Baking Application Center	CI
25-05-19	BRAIN Biotech AG acquired remaining minority stake in Breatec B.V.	CI
25-04-30	Brain Biotech Ag Updates Earnings Guidance for the Full Year 2025	CI
25-02-26	BRAIN Biotech AG Reports Earnings Results for the First Quarter Ended December 31, 2024	CI
25-02-13	BRAIN Biotech AG Collaborates with PX Group on the PX Urban Mining Initiative	CI
25-01-14	BRAIN Biotech AG Reports Earnings Results for the Full Year Ended September 30, 2024	CI
24-12-12	BRAIN Biotech AG - Analyst/Investor Day
24-10-03	BRAIN Biotech AG Announces Resignation of Wiltrud Treffenfeldt as Member of the Supervisory Board	CI
24-09-23	Brain Biotech Signs EUR129 Million Royalty Deal for Hereditary Angioedema Treatment Compound	MT
24-08-29	BRAIN Biotech AG Reports Earnings Results for the Third Quarter and Nine Months Ended June 30, 2024	CI
24-05-28	BRAIN Biotech AG Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2024	CI
24-04-16	Brain Biotech Plans Merger by Absorption of AnalytiCon Discovery	MT
24-03-05	BRAIN Biotech AG and AMSilk GmbH Announce the Successful Completion of the First Phase of A Development Collaboration	CI
24-02-28	BRAIN Biotech AG Reports Earnings Results for the First Quarter Ended December 31, 2023	CI
24-01-17	BRAIN Biotech AG Reports Earnings Results for the Full Year Ended September 30, 2023	CI